Clearing feeding tubes faster – Biotech’s future

submitted by: nsf

Feeding tubes often become clogged with medication and food, depriving patients of nutrition. NSF-funded small business Actuated Medical has invented an FDA-approved device that clears clogs quickly and cleanly. Roger Bagwell demonstrated how the device works at the 2014 BIO International Convention.

Health care that follows you from home to hospital and back

submitted by: nsf
Professor Marjorie Skubic from the University of Missouri has created a suite of health care technologies that identify when an individual falls in their home or when their physical behavior changes over time. However, how does a physician at a hospital know about and use information gathered by devices like those designed by Skubic for the home? And likewise, how does information about a patient's condition in the hospital get incorporated into technologies like Skubic's when they return...

Targeted Drug Melts Fat in Obese Monkeys

submitted by: mdanderson
An anti-obesity drug that homes in on and destroys blood vessels that support fat reduced the weight of obese rhesus monkeys by 11 percent in one month. It also trimmed their waistlines by eradicating 27 percent of their abdominal fat. Obesity raises a person's risk for developing breast, ovarian, prostate, colon and other cancers and also hinders treatment for cancer patients. Scientists at The University of Texas MD Anderson Cancer Center who developed the drug discuss results of the...

All Obstacles Removed ... the Journey Continues for Brain Cancer Patient

submitted by: mdanderson
Aidan Immroth lost his battle to brain cancer in November of this year, but at the end of his brief 13 years on this earth, Aidan accomplished something really huge -- actually as big as an elephant -- a painting using a live elephant as the canvas that is! Part of the Pediatric Education and Creative Arts Program at MD Anderson Children's Cancer Hospital, Aidan had a vision to paint a real elephant and it became reality through the help of Ian Cion, MD Anderson Children's Cancer Hospital's...

Targeted Lymphoma Drug Works After Others Fail

submitted by: mdanderson

MD Anderson's Dr. Michelle Fanale, Hodgkin lymphoma survivor Alexandra Medina and research nurse Rinata Simien talk about newly approved drug brentuximab vedotin.

The Biology of Genomes (2008) with David Bentley Interviewed by Chris Gunter

Dr. David Bentley is Vice President and Chief Scientist at Illumina Inc, developing new DNA sequencing technology for fast, accurate sequencing of complex genomes. His major research interest is the study of human sequence variation. He was previously Head of Human Genetics and founding Member of the Board of Management at the Wellcome Trust Sanger Institute, where he played leading roles in the Institute's contribution the human genome reference sequence, The SNP Consortium and the...

Sodium Channels and Pain

submitted by: alex01

S. Waxman, MD, PhD. - Medical need for new analgesics is discussed by S. Waxman (Yale University) who evaluated the role of selective subtypes of sodium channels, particularly 1.7 and 1.8 subtypes, in the perception of pain. There is an unmet medical need for drugs to treat chronic pain and inhibitors of
selective sodium channels are in development as novel analgesics.

MacArthur Fellow 2008: Peter Pronovost, physician

submitted by: video_collector
Peter Pronovost is a critical care physician devising life-saving, clinical practices to improve patient safety in hospitals and spare countless lives from deadly consequences of human error. MacArthur Fellowships offer the opportunity for Fellows to accelerate their current activities or take their work in new directions. The unusual level of independence afforded to Fellows underscores the spirit of freedom intrinsic to creative endeavors. The extraordinary creativity of MacArthur...